alphaveVIVOBIOT₹16.99

Vivo Bio Tech Limited

₹ Crore

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025
Non-current Assets
+ Property, Plant & Equipment	68.9	61.0
+ Capital Work-in-Progress	9.2	12.8
+ Other Intangibles	8.1	23.9
+ Non-current Investments	0.0	0.0
Non-current Financial Assets	0.0	0.0
+ Other Non-current Assets	0.3	0.2
Total Non-current Assets	86.6	98.0
Current Assets
+ Inventories	8.8	7.8
+ Trade Receivables	11.4	11.2
+ Cash & Cash Equivalents	1.3	1.2
+ Short-term Loans	25.7	22.3
Current Financial Assets	38.4	34.8
+ Other Current Assets	1.1	0.8
Total Current Assets	48.2	43.3
Total Assets	134.8	141.3
Equity
+ Equity Share Capital	14.9	17.2
+ Other Equity / Reserves	39.5	61.0
Equity — Owners of Parent	54.4	78.2
Total Equity	54.4	78.2
Liabilities
+ Borrowings — Non-current	39.6	32.7
Non-current Financial Liabilities	39.6	32.7
+ Deferred Tax Liabilities	2.3	1.8
+ Other Non-current Liabilities	0.7	0.8
Non-current Liabilities	42.6	35.3
+ Borrowings — Current	31.3	19.1
+ Trade Payables	1.1	1.0
Current Financial Liabilities	32.3	20.1
+ Provisions — Current	5.5	7.8
Current Liabilities	37.8	27.8
Total Liabilities	80.4	63.1
Total Equity & Liabilities	134.8	141.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.